3 mg melatonin

DRUG2 trials

Sponsors

Providence Health & Services, Fayoum University

Conditions

Impacted Third Molar ToothRelapsing Remitting Multiple Sclerosis

Early Phase 1

Melatonin in Patients With Multiple Sclerosis (MS).

CompletedNCT03498131

Providence Health & ServicesRelapsing Remitting Multiple Sclerosis

Start: 2018-05-09End: 2023-12-11Updated: 2025-03-30

Phase 3

The Effect of Melatonin Application Following Removal of Impacted Third Molar

CompletedNCT04424875

Fayoum UniversityImpacted Third Molar Tooth

Start: 2020-07-01End: 2021-05-01Updated: 2021-05-18

Related Papers

Impact of oral melatonin supplementation on urine and serum melatonin concentrations and quality-of-life measures in persons with relapsing multiple sclerosis.

2024-08-03